China functional food firm BuffX has outlined its strategy to outgrow the bottleneck seen in tier one and two cities – by launching powder-based ‘breakfasts’ in lower tier cities formulated using traditional Chinese medicines (TCM) concepts.
Canada’s Tait Laboratories is planning to export its digestive health supplement to China as well as pushing the concept of ‘clean’ TCM ingredients in the region on the back of a new patent for its extraction technology for citrus peels.
Integrative medicine offers vast opportunities to improve the diagnosis and treatment of patients, but more randomised clinical trials, better quality control, and clearer health indications are required, according to veteran TCM researcher Professor...
Yiling Pharmaceutical, the company behind TCM/dietary supplement product Lianhua Qingwen, said revenue from its overseas market was up 918.37 per cent in FY2020, after the product was officially recognised by the China authorities as a COVID-19 standard...
New regulations in Australia is making research on the role of complementary medicine, including Chinese medicine, to manage chronic diseases more attractive, according to a prominent researcher who stars in the 15th episode of our NutraChampion podcast.
Malaysia headquartered Ritamix Global has launched a tea modelled on a TCM formula used in China for COVID-19 treatment – but the new product is registered as food and beverage and makes no health claims.
China consumers are placing more trust in traditional Chinese medicines (TCM), with a declining interest in overseas supplement brands and functional foods with health claims, said a consumer survey funded by the High-Value Nutrition National Science...
Blackmores CEO Alastair Symington has told us the firm decided to sell its traditional Chinese medicine (TCM) and oriental botanical supplement arm Global Therapeutics amid a decline in the segments’ main retail channel – health food stores.
Australia’s Therapeutic Goods Administration (TGA) will conduct compliance checks on listed medicines that are based on TCM, Ayurveda or other traditional paradigms, with firms urged to re-evaluate their products.
A two-week clinical trial led by renowned Chinese pulmonologist Zhong Nanshan has shown that consuming the botanical TCM product Lianhua Qingwen (LH) capsules and undergoing the standard therapy can speed up recovery in COVID-19 patients.
Researchers from Asia, the Middle East, and the West are now trialling omega-3, honey, and even potato resistant starch, on top of vitamins and zinc, as they race to find products that could contribute to the fight against COVID-19 and its symptoms.
China is conducting clinical trials to assess the effectiveness and safety of combining traditional Chinese medicine (TCM) and conventional Western antiviral medicine in the treatment of patients with the novel coronavirus (COVID-19).
In this round-up of new developments happening in China’s health and nutrition supplement industry, we shed light on the upcoming consumption trends for this year, including the up-and-coming A2 milk market.
Japanese company Health Business Info is on a mission to expand the use of sika deer in dietary supplements, using it as a key ingredient to aid sleep based on a traditional Chinese medicine (TCM) concept.
Nootropics in New Zealand, cordyceps in South Korea, and the impact of China's daigou clampdown on companies like Swisse owner H&H all feature among our five most read stories on social media this month.